Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cocrystal Pharma Inc
COCPCurrent price
2.2 USD
-0.01 USD (-0.45%)
Last closed
2.22 USD
Company
www.cocrystalpharma.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
23 908 430 USD
Yield for 12 month
-12.70 %
1Y
3Y
5Y
10Y
15Y
COCP
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington. Address: 19805 North Creek Parkway, Bothell, WA, United States, 98011
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+144 000 USD
Current Year
+1 388 000 USD
Last Year
-241 600 USD
Current Quarter
-35 000 USD
Last Quarter
+72 000 USD
Key Figures COCP
1 year
3 years
5 years
10 years
EBITDA
-20 031 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-39.23 %
PEG Ratio
–
Return On Equity TTM
-58.52 %
Wall Street Target Price
10 USD
Revenue TTM
510 000 USD
Book Value
2.22 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
26.9 %
Dividend Yield
–
Gross Profit TTM
-8 794 000 USD
Earnings per share
-1.62 USD
Diluted Eps TTM
-1.62 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics COCP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History COCP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
11.10.2022
Dividend Date
24.01.2018
Stock Valuation COCP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
17.8912
Price Sales TTM
92.4548
Enterprise Value EBITDA
0.4607
Price Book MRQ
0.5591
Financials COCP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators COCP
For 52 weeks
1.33 USD
3.29 USD
50 Day MA
2.32 USD
Shares Short Prior Month
6 054
200 Day MA
1.8 USD
Short Ratio
0.46
Shares Short
18 063
Short Percent
0.23 %
BeatStart